Emerging viral diseases: confronting threats with new technologies.
Hilary D Marston, Gregory K Folkers, David M Morens, Anthony S Fauci
Author Information
Hilary D Marston: National Institute of Allergy and Infectious Diseases at the National Institutes of Health, Bethesda, MD 20892, USA.
Gregory K Folkers: National Institute of Allergy and Infectious Diseases at the National Institutes of Health, Bethesda, MD 20892, USA.
David M Morens: National Institute of Allergy and Infectious Diseases at the National Institutes of Health, Bethesda, MD 20892, USA.
Anthony S Fauci: National Institute of Allergy and Infectious Diseases at the National Institutes of Health, Bethesda, MD 20892, USA. afauci@niaid.nih.gov.
Emerging viral diseases pose ongoing health threats, particularly in an era of globalization; however, new biomedical research technologies such as genome sequencing and structure-based vaccine and drug design have improved our ability to respond to viral threats.
